Early Deferasirox Treatment in a Patient with Myelodysplastic Syndrome Results in a Long-Term Reduction in Transfusion Requirements

被引：23

作者：

Capalbo, Silvana ^{[1
]}

Spinosa, Giuseppina ^{[1
]}

Franzese, Maria Grazia ^{[1
]}

Palumbo, Gaetano ^{[1
]}

机构：

[1] Azienda Osped Univ, Osped Riuniti Foggia, Dept Hematol, IT-71100 Foggia, Italy

来源：

ACTA HAEMATOLOGICA | 2009年 / 121卷 / 01期

关键词：

Deferasirox; Iron chelation; Myelodysplastic syndrome; IRON CHELATION; ERYTHROPOIESIS; MYELOFIBROSIS; ANEMIA; IMPACT;

D O I：

10.1159/000209206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：19 / 20

页数：2

共 11 条

[1] Early clinical impact of iron overload in stem cell transplantation. A prospective study [J].

Altes, Albert ;

Remacha, Angel Francisco ;

Sarda, Pilar ;

Baiget, Montserrat ;

Sureda, Anna ;

Martino, Rodrigo ;

Briones, Javier ;

Brunet, Salut ;

Canals, Carme ;

Sierra, Jorge .

ANNALS OF HEMATOLOGY, 2007, 86 (06) :443-447

[2] Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation [J].

Armand, Philippe ;

Kim, Haesook T. ;

Cutler, Corey S. ;

Ho, Vincent T. ;

Koreth, John ;

Alyea, Edwin P. ;

Soiffer, Robert J. ;

Antin, Joseph H. .

BLOOD, 2007, 109 (10) :4586-4588

[3] The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload [J].

Camaschella, Clara ;

Campanella, Alessandro ;

De Falco, Luigia ;

Boschetto, Loredana ;

Merlini, Roberta ;

Silvestri, Laura ;

Levi, Sonia ;

Iolascon, Achille .

BLOOD, 2007, 110 (04) :1353-1358

[4]

Cappellini Maria Domenica, 2007, Ther Clin Risk Manag, V3, P291, DOI 10.2147/tcrm.2007.3.2.291

[5] Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670) [J].

Di Tucci, Anna Angela ;

Murru, Roberta ;

Alberti, Daniele ;

Rabault, Bertrand ;

Deplano, Simona ;

Angelucci, Emanuele .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (06) :540-542

[6] The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload [J].

Jensen, PD ;

Heickendorff, L ;

Pedersen, B ;

BendixHansen, K ;

Jensen, FT ;

Christensen, T ;

Boesen, AM ;

Ellegaard, J .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (02) :288-299

[7] Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making [J].

Malcovati, L ;

Della Porta, MG ;

Pascutto, C ;

Invernizzi, R ;

Boni, M ;

Travaglino, E ;

Passamonti, F ;

Arcaini, L ;

Maffioli, M ;

Bernasconi, P ;

Lazzarino, M ;

Cazzola, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7594-7603

[8] Deferasirox Treatment Improved the Hemoglobin Level and Decreased Transfusion Requirements in Four Patients with the Myelodysplastic Syndrome and Primary Myelofibrosis [J].

Messa, E. ;

Cilloni, D. ;

Messa, F. ;

Arruga, F. ;

Roetto, A. ;

Saglio, G. .

ACTA HAEMATOLOGICA, 2008, 120 (02) :70-74

[9]

Smeets MEP, 1996, AM J HEMATOL, V51, P243, DOI 10.1002/(SICI)1096-8652(199603)51:3<243::AID-AJH12>3.0.CO

[10]

2-H

← 1 2 →